Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which sedation method makes cataract surgery more comfortable?

NCT ID NCT06506669

Symptom relief Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This pilot study compares two sedation approaches for cataract surgery: one uses oral medication to reduce anxiety, the other uses a placebo. The goal is to see which approach leads to higher patient satisfaction and better recovery. The study involves 23 adults aged 60 and older who are planning cataract surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Oral sedation (medication for anxiety) vs placebo
What this could lead to
If successful, this could help identify the best sedation approach for cataract surgery, improving patient comfort and satisfaction.
What could go wrong
This is a small pilot study with only 23 participants, so results may not apply to everyone. The study is designed to test feasibility, not to prove which method is better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

23 people

The number who actually took part.

Started

Jun 2024

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. ≥ 60 years old 2. Capable of providing informed consent and completing the study procedures in English 3. Able to provide consent for oneself 4. Able to follow directions 5. Able to climb one flight of stairs without stopping to rest 6. Have a new diagnosis of cataract disease 7. Plan on having cataract surgery on their eye within the next 6 months Exclusion Criteria: 1. History of prior cataract surgery 2. Admission to the hospital within the past 30 days 3. Difficulty being sedated during other minor outpatient procedures or imaging studies 4. Allergy or resistance to local anesthetic agents 5. Cannot lay flat on your back without having symptoms (i.e., difficulty breathing, severe back pain, etc.) 6. History of severe anxiety requiring routine use of benzodiazepines 7. Severe valve disease (e.g., critical aortic stenosis) 8. Cardiac conditions requiring an implanted cardiac device such as a pacemaker, defibrillator, or left ventricular assist device (for arrhythmia, congestive heart failure, etc.) 9. Untreated chest pain or angina 10. Patients with movement disorders (e.g., Parkinson's Disease) 11. History of Cerebral Vascular Accident (CVA), Transient Ischemic Attack (TIA), or seizures 12. Require home oxygen (O2) at rest or with exertion 13. End-stage renal disease (ESRD) requiring dialysis 14. Morbid obesity (BMI\>35) 15. Patient undergoing cataract surgery in combination with any other ophthalmologic procedure 16. Patient requiring general anesthesia during cataract surgery due to the underlying characteristics of the existing cataract and/or anticipated complexity of the planned procedure

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract Patient Satisfaction senile cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anesthesia Bilateral senile cataract Cataract Patient satisfaction

Contacts and locations

Locations

  • University of California, San Francisco

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.